当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い

オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得

インデックス付き
  • 索引コペルニクス
  • Google スカラー
  • Jゲートを開く
  • Genamics JournalSeek
  • 中国国家知識基盤 (CNKI)
  • 電子ジャーナルライブラリ
  • レフシーク
  • ハムダード大学
  • エブスコ アリゾナ州
  • OCLC-WorldCat
  • 仮想生物学図書館 (vifabio)
  • パブロン
  • ジュネーブ医学教育研究財団
  • ユーロパブ
  • ICMJE
このページをシェアする

抽象的な

End-of-Life Decision Making in the Context of Chronic Life-Limiting Disease

Sarah King

Variability in practice, insufficient predictive models for death, elusive knowledge of patient preferences, poor communication between staff and surrogates, insufficient or absent training of health-care providers, the use of imprecise and insensitive terminology, and incomplete documentation in medical records were among the issues identified by the jurors. The research towards improving end-of-life care is performed. The verdict recommends a "shared" approach to end-of-life decision-making that includes caregivers and patient surrogates. Respect for the autonomy of the patient, as well as the desire to honor the patient's decision to refuse undesirable therapies, should be communicated to the family. The negotiating process will decide the conclusion, which will be influenced by the personalities and beliefs of the players. In the end, it is the Variability in practice, insufficient predictive models for death, elusive knowledge of patient preferences, poor communication between staff and surrogates, insufficient or absent training of health-care providers, the use of imprecise and insensitive terminology, and incomplete documentation in medical records were among the issues identified by the jurors. The research towards improving end-of-life care is performed. The verdict recommends a "shared" approach to end-of-life decision-making that includes caregivers and patient surrogates. The sufferer must be guaranteed a painless death. The Consensus Conference jury agrees with the moral and legal grounds prohibiting the administration of therapies intended to hasten death. The patient must be provided enough analgesia to relieve pain and anguish; if this analgesia hastens death, the "double impact" should not detract from the primary goal of providing comfort